Cargando…
Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective
Background: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a rare, genetically determined neurological disorder, for which Ketogenic Diet (KD) represents the gold standard life-long treatment. The aim of this study is to investigate health related quality of life in a well characterized...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682968/ https://www.ncbi.nlm.nih.gov/pubmed/31330987 http://dx.doi.org/10.3390/nu11071650 |
_version_ | 1783441987437854720 |
---|---|
author | Varesio, Costanza Pasca, Ludovica Parravicini, Stefano Zanaboni, Martina Paola Ballante, Elena Masnada, Silvia Ferraris, Cinzia Bertoli, Simona Tagliabue, Anna Veggiotti, Pierangelo De Giorgis, Valentina |
author_facet | Varesio, Costanza Pasca, Ludovica Parravicini, Stefano Zanaboni, Martina Paola Ballante, Elena Masnada, Silvia Ferraris, Cinzia Bertoli, Simona Tagliabue, Anna Veggiotti, Pierangelo De Giorgis, Valentina |
author_sort | Varesio, Costanza |
collection | PubMed |
description | Background: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a rare, genetically determined neurological disorder, for which Ketogenic Diet (KD) represents the gold standard life-long treatment. The aim of this study is to investigate health related quality of life in a well characterized cohort of patients affected by GLUT1DS treated with KD, evaluating factors that can influence patients’ and parents’ quality of life perception. Methods: This is a double center exploratory research study. A postal survey with auto-administrable questionnaires was conducted among 17 subjects (aged 3–22 years) with diagnosis of GLUT1DS, receiving a stable KD treatment for more than 1 year. The Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales was adopted. Clinical variables analyzed in relation to quality of life were frequency of epileptic seizures and movement disorder since KD introduction, presence of intellectual disability (ID), and KD ratio. Results: Quality of life global scores were impaired both in parents’ and children’s perspectives, with a significant concordance. Taking into consideration subscales, the average was 64.17 (range 10–100) for physical functioning, 74.23 (range 30–100) for emotional functioning, 62.64 (range 10–100) for social functioning, and 56 (range 15–92) for school functioning. Conclusions: In patients with GLUT1DS the quality of life perception is comparable to that of other patients with chronic disease. In our sample, the presence of movement disorder seems to be a crucial element in quality of life perception. |
format | Online Article Text |
id | pubmed-6682968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66829682019-08-09 Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective Varesio, Costanza Pasca, Ludovica Parravicini, Stefano Zanaboni, Martina Paola Ballante, Elena Masnada, Silvia Ferraris, Cinzia Bertoli, Simona Tagliabue, Anna Veggiotti, Pierangelo De Giorgis, Valentina Nutrients Article Background: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a rare, genetically determined neurological disorder, for which Ketogenic Diet (KD) represents the gold standard life-long treatment. The aim of this study is to investigate health related quality of life in a well characterized cohort of patients affected by GLUT1DS treated with KD, evaluating factors that can influence patients’ and parents’ quality of life perception. Methods: This is a double center exploratory research study. A postal survey with auto-administrable questionnaires was conducted among 17 subjects (aged 3–22 years) with diagnosis of GLUT1DS, receiving a stable KD treatment for more than 1 year. The Pediatric Quality of Life Inventory (PedsQL) 4.0 Generic Core Scales was adopted. Clinical variables analyzed in relation to quality of life were frequency of epileptic seizures and movement disorder since KD introduction, presence of intellectual disability (ID), and KD ratio. Results: Quality of life global scores were impaired both in parents’ and children’s perspectives, with a significant concordance. Taking into consideration subscales, the average was 64.17 (range 10–100) for physical functioning, 74.23 (range 30–100) for emotional functioning, 62.64 (range 10–100) for social functioning, and 56 (range 15–92) for school functioning. Conclusions: In patients with GLUT1DS the quality of life perception is comparable to that of other patients with chronic disease. In our sample, the presence of movement disorder seems to be a crucial element in quality of life perception. MDPI 2019-07-19 /pmc/articles/PMC6682968/ /pubmed/31330987 http://dx.doi.org/10.3390/nu11071650 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Varesio, Costanza Pasca, Ludovica Parravicini, Stefano Zanaboni, Martina Paola Ballante, Elena Masnada, Silvia Ferraris, Cinzia Bertoli, Simona Tagliabue, Anna Veggiotti, Pierangelo De Giorgis, Valentina Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective |
title | Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective |
title_full | Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective |
title_fullStr | Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective |
title_full_unstemmed | Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective |
title_short | Quality of Life in Chronic Ketogenic Diet Treatment: The GLUT1DS Population Perspective |
title_sort | quality of life in chronic ketogenic diet treatment: the glut1ds population perspective |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682968/ https://www.ncbi.nlm.nih.gov/pubmed/31330987 http://dx.doi.org/10.3390/nu11071650 |
work_keys_str_mv | AT varesiocostanza qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT pascaludovica qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT parravicinistefano qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT zanabonimartinapaola qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT ballanteelena qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT masnadasilvia qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT ferrariscinzia qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT bertolisimona qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT tagliabueanna qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT veggiottipierangelo qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective AT degiorgisvalentina qualityoflifeinchronicketogenicdiettreatmenttheglut1dspopulationperspective |